1. Home
  2. TRMK vs RCUS Comparison

TRMK vs RCUS Comparison

Compare TRMK & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trustmark Corporation

TRMK

Trustmark Corporation

HOLD

Current Price

$45.94

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$26.87

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRMK
RCUS
Founded
1889
2015
Country
United States
United States
Employees
N/A
601
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.2B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
TRMK
RCUS
Price
$45.94
$26.87
Analyst Decision
Hold
Buy
Analyst Count
2
10
Target Price
$44.50
$31.90
AVG Volume (30 Days)
308.5K
1.4M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
2.26%
N/A
EPS Growth
1.93
N/A
EPS
2.03
N/A
Revenue
N/A
$247,000,000.00
Revenue This Year
$9.82
N/A
Revenue Next Year
$4.86
$45.62
P/E Ratio
$22.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.33
$12.15
52 Week High
$49.00
$31.74

Technical Indicators

Market Signals
Indicator
TRMK
RCUS
Relative Strength Index (RSI) 49.66 44.73
Support Level $45.03 $25.94
Resistance Level $47.81 $31.47
Average True Range (ATR) 0.97 1.17
MACD 0.04 -0.19
Stochastic Oscillator 56.96 38.79

Price Performance

Historical Comparison
TRMK
RCUS

About TRMK Trustmark Corporation

Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: